These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10063787)

  • 21. Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.
    Radchenko GD; Sirenko YM; Kushnir SM; Torbas OO; Dobrokhod AS
    Vasc Health Risk Manag; 2013; 9():535-49. PubMed ID: 24109189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension.
    Frishman WH; Burris JF; Mroczek WJ; Weir MR; Alemayehu D; Simon JS; Chen SY; Bryzinski BS
    J Clin Pharmacol; 1995 Feb; 35(2):182-8. PubMed ID: 7751430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical results with bisoprolol 2.5 mg/hydrochlorothiazide 6.25 mg combination in systolic hypertension in the elderly.
    Benetos A; Adamopoulos C; Argyriadis P; Bean K; Consoli S; Safar M
    J Hypertens Suppl; 2002 Feb; 20(1):S21-5. PubMed ID: 11996196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.
    Duprez D; Ferdinand K; Purkayastha D; Samuel R; Wright R
    Vasc Health Risk Manag; 2011; 7():701-8. PubMed ID: 22174580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension.
    Lacourcière Y; Poirier L; Lefebvre J; Archambault F; Cléroux J; Boileau G
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1154-9. PubMed ID: 8998248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress report on the first sub-Saharan Africa trial of newer versus older antihypertensive drugs in native black patients.
    Odili AN; Ezeala-Adikaibe B; Ndiaye MB; Anisiuba BC; Kamdem MM; Ijoma CK; Kaptue J; Boombhi HJ; Kolo PM; Shu EN; Thijs L; Staessen JA; Omotoso BA; Kingue S; Ba SA; Lemogoum D; M'Buyamba-Kabangu JR; Ulasi II
    Trials; 2012 May; 13():59. PubMed ID: 22594907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety.
    Calhoun DA; Crikelair NA; Yen J; Glazer RD
    Adv Ther; 2009 Nov; 26(11):1012-23. PubMed ID: 20024680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension.
    McGill JB; Reilly PA
    Clin Cardiol; 2001 Jan; 24(1):66-72. PubMed ID: 11195609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy.
    Weir MR; Prisant LM; Papademetriou V; Weber MA; Adegbile IA; Alemayehu D; Lefkowitz MP
    Am J Hypertens; 1996 Sep; 9(9):854-9. PubMed ID: 8879341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
    Hiltunen TP; Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Virolainen J; Kontula K
    Am J Hypertens; 2007 Mar; 20(3):311-8. PubMed ID: 17324745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
    Punzi HA
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of aliskiren/hydrochlorothiazide combination therapy and amlodipine monotherapy in patients with stage 2 systolic hypertension and type 2 diabetes mellitus.
    Townsend RR; Forker AD; Bhosekar V; Yadao A; Keefe DL
    J Clin Hypertens (Greenwich); 2011 Dec; 13(12):889-97. PubMed ID: 22142348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensives.
    Weir MR; Ferdinand KC; Flack JM; Jamerson KA; Daley W; Zelenkofske S
    Hypertension; 2005 Sep; 46(3):508-13. PubMed ID: 16116046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Essential Hypertension (RESOLVE): A Large, Observational, Retrospective, Cohort Study.
    Park SJ; Rhee SJ
    Adv Ther; 2020 Aug; 37(8):3500-3514. PubMed ID: 32557349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial.
    Sohn IS; Kim CJ; Oh BH; Hong TJ; Park CG; Kim BS; Chung WB;
    Am J Cardiovasc Drugs; 2016 Apr; 16(2):129-38. PubMed ID: 26691333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension.
    Fogari R; Mugellini A; Derosa G;
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):139-44. PubMed ID: 17907102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
    Oparil S; Chrysant SG; Melino M; Lee J; Karki S; Heyrman R
    J Hum Hypertens; 2010 Dec; 24(12):831-8. PubMed ID: 20200547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.
    Zappe D; Papst CC; Ferber P;
    Vasc Health Risk Manag; 2009; 5():883-92. PubMed ID: 19898644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of eprosartan and enalapril in the treatment of black hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
    Levine B
    Curr Med Res Opin; 1999; 15(1):25-32. PubMed ID: 10216808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.